$15.95
-0.03-0.19%
Last update: 4:53 PM
15 minutes delayed
Tourmaline Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tourmaline Bio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $-0.55 | $-0.67 | 17.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Tourmaline Bio (TRML) is scheduled to report earnings on August 15, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
The Actual EPS was $-0.55, which beat the estimate of $-0.67.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.